PRISMA for Diagnostic Test Accuracy
The PRISMA extension for diagnostic test accuracy (DTA) studies was published in 2018. The extension can facilitate the transparent reporting of systematic reviews including DTA studies, and may assist in the evaluation of validity and applicability, enhance replicability of reviews, and make the results from systematic reviews of DTA studies more useful.
Key documents
Statement paper: McInnes MDF, Moher D, Thombs BD, et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement. JAMA. 2018;319(4):388-396. doi: 10.1001/jama.2017.19163
Explanation and Elaboration paper: Salameh JP, Bossuyt PM, McGrath TA, Thombs BD, Hyde CJ, Macaskill P, et al. Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist. BMJ 2020;370:m2632. doi: 10.1136/bmj.m2632
Abstracts paper: Cohen JF, Deeks JJ, Hooft L, Salameh JP, Korevaar D, Gatsonis C, et al. Preferred reporting items for journal and conference abstracts of systematic reviews and meta-analyses of diagnostic test accuracy studies (PRISMA-DTA for Abstracts): checklist, explanation, and elaboration. BMJ 2021;372:n265. doi: 10.1136/bmj.n265